{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T10:22:49Z","timestamp":1772187769299,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 22K07281"],"award-info":[{"award-number":["JP 22K07281"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although radiotherapy including the internal mammary lymph nodes (IMN) after breast surgery improves the prognosis of breast cancer, it may also increase radiation exposure to the heart and lungs due to the expanded irradiation field. Effectively and safely delivering radiation to the IMN region remains a clinical challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>At our institution, we originally developed a hybrid volumetric-modulated arc therapy (Hybrid VMAT) technique that combines conventional tangential fields with VMAT for postoperative breast cancer patients requiring irradiation to the conserved breast or chest wall and regional lymph nodes. In this study, we evaluated the safety, efficacy, and dosimetric performance of Hybrid VMAT in postoperative breast cancer patients whose treatment included the IMN region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 57 patients who received Hybrid VMAT covering the chest wall or breast and regional lymph nodes, including the IMN region, between January 2016 and March 2023. Most patients (n\u2009=\u200953) underwent preoperative chemotherapy, and 44 had IMN metastases at diagnosis. The standard dose was 50\u00a0Gy in 25 fractions, with a 10\u00a0Gy boost in selected cases. Dosimetric parameters (Conformity index (CI), Homogeneity index (HI), and Organ at risk (OAR) doses), clinical outcomes (local\/regional control, Progression-free survival (PFS), Overall survival (OS)), and adverse events (such as pneumonitis) were evaluated using CTCAE v5.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median PTV CI and HI were 1.284 and 0.100, respectively, with a median IMN HI of 0.056. Mean heart and bilateral lung doses were kept low at 4.3 and 9.1\u00a0Gy, respectively. Median follow-up was 26\u00a0months. The 2\u00a0years local control, PFS, and OS rates were 96.3%, 79.2%, and 91.4%, respectively. No\u2009\u2265\u2009Grade 2 radiation pneumonitis occurred.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This original Hybrid VMAT technique offers a clinically viable solution for balancing adequate IMN coverage and OAR protection, enabling safe combination with systemic therapies for breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11604-025-01910-6","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:59:09Z","timestamp":1763632749000},"page":"531-538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dosimetric analysis and clinical outcomes including adverse events in postoperative breast cancer irradiation involving the internal mammary lymph node region using Hybrid VMAT"],"prefix":"10.1007","volume":"44","author":[{"given":"Soichiro","family":"Ishihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0047-994X","authenticated-orcid":false,"given":"Yoshiko","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideharu","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kenjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"1910_CR1","doi-asserted-by":"crossref","unstructured":"Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10801 women in 17 randomised trials. Lancet. 2011; 12;378(9804):1707\u201316.","DOI":"10.1016\/S0140-6736(11)61629-2"},{"key":"1910_CR2","doi-asserted-by":"crossref","unstructured":"McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014; 21;383(9935):2127\u201335.","DOI":"10.1016\/S0140-6736(14)60488-8"},{"key":"1910_CR3","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG). Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14\u2009324 women in 16 trials. Lancet. 2023; 25;402(10416):1991\u20132003."},{"issue":"49","key":"1910_CR4","first-page":"101160","volume":"12","author":"AWM Nielsen","year":"2024","unstructured":"Nielsen AWM, Thorsen LBJ, \u00d6zcan D, Matthiessen LW, Maae E, Milo MLH, et al. Internal mammary node irradiation in 4541 node-positive breast cancer patients treated with newer systemic therapies and 3D-based radiotherapy (DBCG IMN2): a prospective, nationwide, population-based cohort study. Lancet Reg Health Eur. 2024;12(49):101160.","journal-title":"Lancet Reg Health Eur"},{"key":"1910_CR5","doi-asserted-by":"crossref","unstructured":"Doi Y, Nakao M, Miura H, Ozawa S, Kenjo M, Nagata Y.\u00a0Hybrid volumetric-modulated arc therapy for postoperative breast cancer including regional lymph nodes: the advantage of dosimetric data and safety of toxicities. J Radiat Res. 2020; 8;61(5):747\u2013754.","DOI":"10.1093\/jrr\/rraa057"},{"key":"1910_CR6","unstructured":"The international commission on Radiation Units and Measurements (ICRU)."},{"issue":"9","key":"1910_CR7","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.21873\/anticanres.17230","volume":"44","author":"T Yano","year":"2024","unstructured":"Yano T, Ono Y, Yoshimura M, Ono T, Sasaki M, Fujimoto T, et al. Postoperative radiotherapy using VMAT for RNI including IMN in breast cancer: report of short-term follow-up. Anticancer Res. 2024;44(9):4011\u20138. https:\/\/doi.org\/10.21873\/anticanres.17230.","journal-title":"Anticancer Res"},{"issue":"23","key":"1910_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.phro.2022.08.004","volume":"13","author":"H Miura","year":"2022","unstructured":"Miura H, Doi Y, Nakao M, Ozawa S, Kenjo M, Nagata Y. Improved treatment robustness of postoperative breast cancer radiotherapy including supraclavicular nodes. Phys Imaging Radiat Oncol. 2022;13(23):153\u20136.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"1910_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.breast.2020.12.011","volume":"55","author":"H Kim","year":"2021","unstructured":"Kim H, Kim SS, Lee IJ, Shin KH, Kim K, Jung J, et al. Outcome of radiotherapy for clinically overt metastasis to the internal mammary lymph node in patients receiving neoadjuvant chemotherapy and breast cancer surgery. Breast. 2021;55:112\u20138.","journal-title":"Breast"},{"issue":"1","key":"1910_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13014-020-1464-0","volume":"15","author":"K Yang","year":"2020","unstructured":"Yang K, Kim H, Choi DH, Park W, Noh JM, Cho WK. Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer. Radiat Oncol. 2020;15(1):16.","journal-title":"Radiat Oncol"},{"issue":"21","key":"1910_CR11","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa2414859","volume":"392","author":"EP Mamounas","year":"2025","unstructured":"Mamounas EP, Bandos H, White JR, Julian TB, Khan AJ, Shaitelman SF, et al. Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy. N Engl J Med. 2025;392(21):2113\u201324.","journal-title":"N Engl J Med"},{"issue":"4","key":"1910_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMoa1415340","volume":"373","author":"TJ Whelan","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373(4):307\u201316.","journal-title":"N Engl J Med"},{"issue":"1","key":"1910_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/jamaoncol.2021.6036","volume":"8","author":"YB Kim","year":"2022","unstructured":"Kim YB, Byun HK, Kim DY, Ahn SJ, Lee HS, Park W, et al. Effect of elective internal mammary node irradiation on disease-free survival in women with node-positive breast cancer: a randomized phase 3 clinical trial. JAMA Oncol. 2022;8(1):96\u2013105.","journal-title":"JAMA Oncol"},{"issue":"3","key":"1910_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.radonc.2013.12.002","volume":"110","author":"Y Abo-Madyan","year":"2014","unstructured":"Abo-Madyan Y, Aziz MH, Aly MM, Schneider F, Sperk E, Clausen S, et al. Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer. Radiother Oncol. 2014;110(3):471\u20136.","journal-title":"Radiother Oncol"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01910-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-025-01910-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01910-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:27:17Z","timestamp":1772184437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-025-01910-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1007\/s11604-025-01910-6","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}